Berkeley testing site of new athletic complex
The tree-sitters may be gone, but what about the possibility of a Native American burial ground?
Archaelogists at UC Berkeley are currently testing land adjacent to the Memorial Stadium on campus in preparation for the construction of a new $140 million athletic center, according to an article in the Daily Californian.
The site, which until September was the site of a large grove of oak trees, may be an ancient Native American burial site, some community members say. They point to newspaper articles printed during the 1920s – when Memorial Stadium was constructed – that suggested Native American remains had been unearthed there.
Campus officials say the archaeological testing is fairly standard for new construction.
UCLA warns students of contagious virus
UCLA officials are warning students and other members of the campus community to beware of a contagious gastrointestinal virus that has already appeared in Los Angeles.
Health workers at the campus health center say the virus can cause fever, headaches, vomiting and severe diarrhea, and the illness typically lasts two to three days, according to a UCLA press release.
Seventy-five students at the University of Southern California have contracted the virus, though no one on the UCLA campus has reported being infected, according to the press release.
Students and staff have been advised to wash their hands carefully before handling or preparing food, before eating and after using the restroom.
Lung cancer vaccine trial begins at UCSD
The first patients have begun enrolling in a new study at UCSD designed to test a new kind of lung cancer vaccine called Lucanix, according to a UC press release.
Like most vaccines, Lucanix is designed to prepare the immune system to fight off a cancer, but it is unique in that it is also engineered to stop the cancer from fighting off the immune system’s activities.
Lyudmilla Bazhenova, director of the lung cancer unit at UCSD’s cancer center, said current methods of dealing with cancer are only so effective.
“The future treatments for advanced lung cancer may involve combinations of chemotherapy and targeted agents, and possibly even biologicals like this,” she said in the press release.
The clinical trial will be conducted at 90 locations worldwide and will include 700 patients with stage four non-small cell lung cancer who have completed four to six cycles of platinum-based chemotherapy.
JEREMY OGUL can be reached at email@example.com.